Loading clinical trials...
Loading clinical trials...
Watchful Waiting in Patients With Good and Intermediate Risk Metastatic Renal Cell Carcinoma; an Imaging Guided Observational Approach. Part of: Towards Patient Tailored Cancer Treatment Supported by Molecular Imaging. IMPACT Study: Imaging Patients for Cancer Drug Selection
Conditions
Interventions
Molecular imaging
Locations
3
Netherlands
VU University Medical Center
Amsterdam, Netherlands
University Medical Center Groningen
Groningen, Netherlands
Radboudumc
Nijmegen, Netherlands
Start Date
December 1, 2014
Primary Completion Date
March 5, 2018
Completion Date
October 19, 2021
Last Updated
December 7, 2021
NCT00033137
NCT07227415
NCT07225114
NCT06680089
NCT05917106
NCT06536439
Lead Sponsor
Radboud University Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions